Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients
<p>Protein tyrosine phosphatase receptor gamma (PTPRG) is a member of the receptor-like family protein tyrosine phosphatases and acts as a tumor suppressor gene in different neoplasms. Recent studies reported the down-regulation of PTPRG expression levels in Chronic Myeloid Leukemia disease (C...
محفوظ في:
| المؤلف الرئيسي: | Mohamed A. Ismail (418629) (author) |
|---|---|
| مؤلفون آخرون: | Marzia Vezzalini (212801) (author), Hisham Morsi (14152881) (author), Ahmad Abujaber (9100064) (author), Ali Al Sayab (4166521) (author), Kodappully Siveen (3520073) (author), Mohamed A. Yassin (8361183) (author), Maria Monne (4166524) (author), Muthanna Samara (11619435) (author), Richard Cook (70389) (author), Claudio Sorio (212799) (author), Helmout Modjtahedi (532099) (author), Nader I. Al-Dewik (14152884) (author) |
| منشور في: |
2022
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Description of PTPRG genetic variants identified in a cohort of Chronic Myeloid Leukemia patients and their ability to influence response to Tyrosine kinase Inhibitors
حسب: Mohamed A. Ismail (418629)
منشور في: (2022) -
Safety and efficacy of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia: A protocol for systematic review and meta-analysis
حسب: Fateen Ata (12217764)
منشور في: (2022) -
Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia
حسب: Luisa Tomasello (702932)
منشور في: (2020) -
The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
حسب: Bara A. Shraim (11753786)
منشور في: (2021) -
FBXW7 tumor suppressor regulation by dualspecificity tyrosine-regulated kinase 2
حسب: Rafael Jiménez-Izquierdo (19482373)
منشور في: (2023)